London–listed PRTech firm Pathos Communications has developed proprietary AI platform PathosMind. For exclusive use by Pathos employees and partners, it surfaces stories that truly resonate with ...

Founded in 2019, Pathos was ranked as the fastest growing advertising and marketing company in the UK in the Financial Times 1000, and the 33rd fastest growing company in Europe in the same ranking.

A British marketing agency ranked among Europe's fastest-growing businesses is planning to float on the London Stock Exchange later this month, The Mail on Sunday understands. Pathos Communications, ...

Trafficking amid that always-just-receding near future of Neuromancer, Watchmen, and other touchstones of late-20th-century sci-fi, Scott Hoffman and Danijel Žeželj’s graphic novel, Nostalgia, leavens ...

TBC - website address containing all information required by AIM Rule 26 will be confirmed in due course and be made live on admission Pathos is a technology-enabled ...

There are many aspects of a car that automakers put a lot of thought into. For instance, it's clear that a lot of time, money, and other resources have been poured into the development of electric ...

PathosLogos Inc., a Tokyo-based HR technology startup, announced today that PathosLogos Combosite has been officially certified as a Workday Global Payroll Connect (GPC) partner. The certification ...

Logos plans to begin deploying satellites in late 2027, pending FCC approvals. Credit: Logos Space Services TAMPA, Fla. — Logos Space Services has raised $50 million to advance engineering plans for ...

Rendering: RMG Housing project on Western Avenue. (Rendering c/o Logos Faith Development) Logos Faith Development, a real estate firm which develops affordable housing projects on underutilized church ...

In the Rhetoric (4th century BCE), Aristotle identified the three modes of persuasion, or persuasive appeals, that are in: the character of the speaker (ethos), the emotions of the audience (pathos), ...

Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, today announced that it has raised $365 million in a late-stage funding. The company didn’t disclose the ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Pathos AI, the biotech drug developer spun out of Tempus ...